Karyopharm Therapeutics | KPTI - Ebit





Ebit Changement Date
AbbVie USD 6.72B 1.99B 2026-06
Abbott USD 2.13B 281M 2026-06
Amgen USD 4.61B 777M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
GlaxoSmithKline GBP 2.6B 312M 2026-06
Incyte USD 700.4M 356.23M 2026-06
J&J USD 7.48B 860M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -31.88M 19.79M 2026-03
Merck USD 840M 2.72B 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Novartis USD 4.73B 549M 2026-06
Novartis USD 4.18B 118M 2026-03
Pfizer USD -180M 5.16B 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Takeda JPY 201.42B 215.04B 2026-06
Tectonic Therapeutic USD -27.3M 5.78M 2026-03
TG Therapeutics USD 21.67M 13.12M 2026-06
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Xencor USD -36.6M 41.26M 2026-06